fluticasone propionate · Glaxo Grp Ltd · NDA 021433
Flovent Hfa
Earliest generic entry, as listed · earliest of 3 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- First generic approved · ANDA 219602, Glenmark Speclt · 021433-001Approved 3 Mar 2026Detected 25 Oct 2026Historical import
- Generic approved · ANDA 219602, Glenmark Speclt · 021433-001Approved 3 Mar 2026Detected 25 Oct 2026Historical import
Products covered · 3
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 021433 · 001 · RLD | aerosol, metered, inhalation | 0.22MG/INH | open |
| 021433 · 002 · RLD | aerosol, metered, inhalation | 0.11MG/INH | open |
| 021433 · 003 · RLD | aerosol, metered, inhalation | 0.044MG/INH | open |